Catherine M. Engelbert

Insider Reports History

Location
110 North Carpenter Street, Chicago, IL
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Catherine M. Engelbert
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine M. Engelbert:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc Director Class A Ordinary Shares 51.1K $1.63M $31.95 May 13, 2025 Direct
Royalty Pharma plc Director Class A Ordinary Shares 43.5K $1.32M $30.23 Jun 7, 2024 Direct
MCDONALDS CORP Director Phantom Stock 3.91K $1.13M $289.89 Dec 31, 2024 Direct
MCDONALDS CORP Director Common Stock 2.08K $602K $289.63 Dec 31, 2024 Direct

Insider Reports Filed by Catherine M. Engelbert

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc May 13, 2025 1 $0 4 May 15, 2025 Director
MCD MCDONALDS CORP Dec 31, 2024 1 $203K 4 Jan 3, 2025 Director
RPRX Royalty Pharma plc Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
MCD MCDONALDS CORP Dec 31, 2023 1 $200K 4 Jan 3, 2024 Director
RPRX Royalty Pharma plc Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
MCD MCDONALDS CORP Apr 3, 2023 1 $10.7K 4 Aug 4, 2023 Director
MCD MCDONALDS CORP Dec 31, 2022 1 $191K 4 Jan 4, 2023 Director
RPRX Royalty Pharma plc Jun 24, 2022 1 $0 4 Jun 24, 2022 Director
MCD MCDONALDS CORP Feb 28, 2022 1 $244K 4 Mar 2, 2022 Director
MCD MCDONALDS CORP Dec 31, 2021 1 $185K 4 Jan 4, 2022 Director
RPRX Royalty Pharma plc Jun 25, 2021 1 $0 4 Jun 29, 2021 Director